These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 730194)

  • 21. [HLA-A, B, C, DR antigens in north Chinese with nasopharyngeal carcinoma].
    Chen R
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1988; 23(2):106-7. PubMed ID: 3153944
    [No Abstract]   [Full Text] [Related]  

  • 22. Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma.
    Butsch Kovacic M; Martin M; Gao X; Fuksenko T; Chen CJ; Cheng YJ; Chen JY; Apple R; Hildesheim A; Carrington M
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2673-7. PubMed ID: 16284396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HLA typing of nasopharyngeal carcinoma in Hunan province].
    Yi YN
    Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):267-9. PubMed ID: 3266851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of cDNA library from NPC tissue and screening of antigenic genes.
    Shu J; He XJ; Li GC
    Cell Mol Immunol; 2006 Feb; 3(1):53-7. PubMed ID: 16549050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological analysis of human leukocyte antigens-A and -B antigens in Thai patients with nasopharyngeal carcinoma.
    Pimtanothai N; Kangwanshiratada O; Charoenwongse P
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S237-41. PubMed ID: 12929995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups.
    Simons MJ; Wee GB; Day NE; Morris PJ; Shanmugaratnam K; De-Thé GB
    Int J Cancer; 1974 Jan; 13(1):122-34. PubMed ID: 4131857
    [No Abstract]   [Full Text] [Related]  

  • 27. Nasopharyngeal carcinoma in Alaskan Eskimos Indians, and Aleuts: a review of cases and study of Epstein-Barr virus, HLA, and environmental risk factors.
    Lanier A; Bender T; Talbot M; Wilmeth S; Tschopp C; Henle W; Henle G; Ritter D; Terasaki P
    Cancer; 1980 Nov; 46(9):2100-6. PubMed ID: 6253051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between immunoglobulin allotypes and susceptibility to nasopharyngeal carcinoma in Malaysia.
    Tarone RE; Levine PH; Yadav M; Pandey JP
    Cancer Res; 1990 Jun; 50(11):3186-8. PubMed ID: 1692255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping.
    Lu CC; Chen JC; Tsai ST; Jin YT; Tsai JC; Chan SH; Su IJ
    Int J Cancer; 2005 Jul; 115(5):742-6. PubMed ID: 15729690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations in nasopharyngeal cancer incidence among specific Chinese communities (dialect groups) in Singapore.
    Shanmugaratnam K
    IARC Sci Publ (1971); 1978; (20):191-8. PubMed ID: 730189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients.
    Whitney BM; Chan AT; Rickinson AB; Lee SP; Lin CK; Johnson PJ
    J Med Virol; 2002 Jul; 67(3):359-63. PubMed ID: 12116028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between nasopharyngeal carcinoma and the HL-A system among Tunisians.
    Betuel H; Camoun M; Colombani J; Day NE; Ellouz R; de-Thé G
    Int J Cancer; 1975 Aug; 16(2):249-54. PubMed ID: 1150352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between microsatellites within the human MHC and nasopharyngeal carcinoma.
    Ooi EE; Ren EC; Chan SH
    Int J Cancer; 1997 Apr; 74(2):229-32. PubMed ID: 9133461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenetic aspects of nasopharyngeal carcinoma. II. Analysis of ABO, rhesus and MNSs red cell systems.
    Hawkins BR; Simons MJ; Goh EH; Chia KB; Shanmugaratnam K
    Int J Cancer; 1974 Jan; 13(1):116-21. PubMed ID: 4206461
    [No Abstract]   [Full Text] [Related]  

  • 35. Nasopharyngeal carcinoma: etiology and control. Recommendations.
    IARC Sci Publ (1971); 1978; (20):591-606. PubMed ID: 215535
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic components in susceptibility to nasopharyngeal carcinoma.
    Kirk RL; Blake NM; Serjeantson S; Simons MJ; Chan SH
    IARC Sci Publ (1971); 1978; (20):283-97. PubMed ID: 730195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin allotypes in patients with nasopharyngeal carcinoma.
    Chaabani H; Ellouz R
    Hum Hered; 1986; 36(6):402-4. PubMed ID: 3793120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-A2 allelic microvariants in nasopharyngeal carcinoma.
    Ren EC; Law GC; Chan SH
    Int J Cancer; 1995 Oct; 63(2):213-5. PubMed ID: 7591206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of HLA monitoring in carcinoma of the nasopharynx].
    Síbl O; Ivasková E; Roubalová K
    Cesk Otolaryngol; 1987 Jul; 36(4):217-23. PubMed ID: 3664697
    [No Abstract]   [Full Text] [Related]  

  • 40. [HLA in cancers of Waldeyer's pharyngeal ring].
    Síbl O; Ivasková E; Veselý J; Sajdlová H
    HNO; 1988 Sep; 36(9):355-8. PubMed ID: 3262607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.